These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28779995)

  • 1. Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al.
    Colombo C; Fugazzola L; Muzza M; Proverbio MC; Cirello V
    Eur J Med Genet; 2018 Feb; 61(2):104-105. PubMed ID: 28779995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
    Zhang T; Xing M
    J Natl Cancer Inst; 2016 Jun; 108(6):djv415. PubMed ID: 26832773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.
    Weeks AL; Wilson SG; Ward L; Goldblatt J; Hui J; Walsh JP
    BMC Med Genet; 2016 Aug; 17(1):60. PubMed ID: 27530615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls.
    Kern B; Coppin L; Romanet P; Crépin M; Szuster I; Renaud F; Leteurtre E; Frénois F; Wemeau JL; Carnaille B; Cardot-Bauters C; Do Cao C; Pigny P
    Eur J Med Genet; 2017 Mar; 60(3):178-184. PubMed ID: 28089742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population.
    de Randamie R; Martos-Moreno GÁ; Lumbreras C; Chueca M; Donnay S; Luque M; Regojo RM; Mendiola M; Hardisson D; Argente J; Moreno JC
    Horm Res Paediatr; 2018; 89(6):397-407. PubMed ID: 29895015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review.
    Colombo C; Muzza M; Proverbio MC; Ercoli G; Perrino M; Cirello V; Vicentini L; Ferrero S; Fugazzola L
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):837-844. PubMed ID: 28222214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HABP2 G534E Variant in Papillary Thyroid Carcinoma.
    Tomsic J; Fultz R; Liyanarachchi S; He H; Senter L; de la Chapelle A
    PLoS One; 2016; 11(1):e0146315. PubMed ID: 26745718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.
    Cirello V; Colombo C; Karapanou O; Pogliaghi G; Persani L; Fugazzola L
    Front Endocrinol (Lausanne); 2020; 11():589340. PubMed ID: 33488516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial non-medullary thyroid cancer: unraveling the genetic maze.
    Peiling Yang S; Ngeow J
    Endocr Relat Cancer; 2016 Dec; 23(12):R577-R595. PubMed ID: 27807061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Familial Non Medullary Thyroid Carcinoma (FNMTC) : a clinical and genetic update].
    Valdes-Socin H; Palmeira L; Burlacu MC; Daly AF; Bours V; Beckers A
    Rev Med Liege; 2016 Dec; 71(12):557-561. PubMed ID: 28387096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BROX haploinsufficiency in familial nonmedullary thyroid cancer.
    Pasquali D; Torella A; Accardo G; Esposito D; Del Vecchio Blanco F; Salvatore D; Sabatino P; Pacini F; Barbato F; Castagna MG; Cantara S; Nigro V
    J Endocrinol Invest; 2021 Jan; 44(1):165-171. PubMed ID: 32385852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series.
    Cantara S; Marzocchi C; Castagna MG; Pacini F
    J Endocrinol Invest; 2017 May; 40(5):557-560. PubMed ID: 27873212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G534E variant in HABP2 is not associated with increased risk of familial nonmedullary thyroid cancer in Brazilian Kindreds.
    de Mello LEB; Araujo AN; Alves CX; de Paiva FJP; Brandão-Neto J; Cerutti JM
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):113-114. PubMed ID: 28418605
    [No Abstract]   [Full Text] [Related]  

  • 14. Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.
    Gara SK; Jia L; Merino MJ; Agarwal SK; Zhang L; Cam M; Patel D; Kebebew E
    N Engl J Med; 2015 Jul; 373(5):448-55. PubMed ID: 26222560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on familial nonmedullary thyroid cancer.
    Ammar SA; Alobuia WM; Kebebew E
    Endocrine; 2020 Jun; 68(3):502-507. PubMed ID: 32162184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
    Simeone P; Alberti S
    J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27418631
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinicopathologic features of familial nonmedullary thyroid carcinoma.
    Fan YF; Zhang B; Yang X; Shang ZH; Liu HF; Xie Y; Liu YW; Gao WS; Wu Q; Li XY
    Chin Med J (Engl); 2015 Apr; 128(8):1037-41. PubMed ID: 25881596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HABP2 Gene Mutations Do Not Cause Familial or Sporadic Non-Medullary Thyroid Cancer in a Highly Inbred Middle Eastern Population.
    Alzahrani AS; Murugan AK; Qasem E; Al-Hindi H
    Thyroid; 2016 May; 26(5):667-71. PubMed ID: 26906432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
    Carvajal-Carmona LG; Tomlinson I; Sahasrabudhe R
    J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27154966
    [No Abstract]   [Full Text] [Related]  

  • 20. HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.
    Pinheiro M; Drigo SA; Tonhosolo R; Andrade SCS; Marchi FA; Jurisica I; Kowalski LP; Achatz MI; Rogatto SR
    Oncotarget; 2017 Jun; 8(25):40896-40905. PubMed ID: 28402931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.